April 01, 2019
Kris Kauno, the clinical trials supervisor at the University of Washington’s Alzheimer’s Disease Research Center/ UW Memory and Brain Wellness Center, is quoted in a STAT article on the ending of the Biogen study: “Talking to families that day was one of the hardest things I have ever had to do.”